Works matching IS 01145916 AND DT 2024 AND VI 47 AND IP 2

Results: 9

SGLT2 Inhibitor Use and Risk of Breast Cancer Among Adult Women with Type 2 Diabetes.

Published in:

Drug Safety, 2024, v. 47, n. 2, p. 125, doi. 10.1007/s40264-023-01373-6

By:

Wang, Fengge;
Hendryx, Michael;
Liu, Nianjun;
Bidulescu, Aurelian;
Mitra, Anirban K.;
Luo, Juhua

Publication type:

Article

Correction to: Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media.

Published in:

2024

By:

Micale, Cristina;
Golder, Su;
O'Connor, Karen;
Weissenbacher, Davy;
Gross, Robert;
Hennessy, Sean;
Gonzalez-Hernandez, Graciela

Publication type:

Correction Notice

Implementation of a Taxonomy-Based Framework for the Selection of Appropriate Drugs and Outcomes for Real-World Data Signal Detection Studies.

Published in:

Drug Safety, 2024, v. 47, n. 2, p. 183, doi. 10.1007/s40264-023-01382-5

By:

Coste, Astrid;
Wong, Angel YS;
Warren-Gash, Charlotte;
Matthewman, Julian;
Bate, Andrew;
Douglas, Ian J.

Publication type:

Article

Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing.

Published in:

Drug Safety, 2024, v. 47, n. 2, p. 173, doi. 10.1007/s40264-023-01381-6

By:

Dong, Guojun;
Bate, Andrew;
Haguinet, François;
Westman, Gabriel;
Dürlich, Luise;
Hviid, Anders;
Sessa, Maurizio

Publication type:

Article

A Descriptive Analysis of Adverse Event Reports from the Quebec Cannabis Registry.

Published in:

Drug Safety, 2024, v. 47, n. 2, p. 161, doi. 10.1007/s40264-023-01379-0

By:

Hachem, Yasmina;
Moride, Yola;
Castilloux, Anne-Marie;
Castillon, Genaro;
Kalaba, Maja;
Néron, Andrée;
Gamaoun, Rihab;
Martel, Marc O.;
Beaulieu, Pierre;
Ware, Mark;
Vigano, Antonio

Publication type:

Article

The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness.

Published in:

Drug Safety, 2024, v. 47, n. 2, p. 117, doi. 10.1007/s40264-023-01376-3

By:

Dickinson, Harriet;
Teltsch, Dana Y.;
Feifel, Jan;
Hunt, Philip;
Vallejo-Yagüe, Enriqueta;
Virkud, Arti V.;
Muylle, Katoo M.;
Ochi, Taichi;
Donneyong, Macarius;
Zabinski, Joseph;
Strauss, Victoria Y.;
Hincapie-Castillo, Juan M.

Publication type:

Article

Appeal for Increasing the Impact of Pharmacovigilance.

Published in:

Drug Safety, 2024, v. 47, n. 2, p. 113, doi. 10.1007/s40264-023-01375-4

By:

Kant, Agnes C.

Publication type:

Article

Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK's Training and Mentoring Pilot Project in the Abidjan Region.

Published in:

Drug Safety, 2024, v. 47, n. 2, p. 147, doi. 10.1007/s40264-023-01368-3

By:

Mendoza, Yolanda Guerra;
Jusot, Viviane;
Adou, Félix;
Ota, Martin;
Elenge, Diego Mpia;
Begum, Tasim;
Mdladla, Nkululeko;
Menang, Olga;
Yavo, Jean Claude;
Kamagaté, Mamadou

Publication type:

Article

Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study.

Published in:

Drug Safety, 2024, v. 47, n. 2, p. 135, doi. 10.1007/s40264-023-01364-7

By:

Qin, Simon Xiwen;
Cheng, Franco Wing Tak;
Kwok, Wang Chun;
Fung, Lydia W. Y.;
Ma, Tian Tian;
Yiu, Hei Hang Edmund;
Bloom, Chloe;
McDonald, Christine F.;
Cheung, Ching-Lung;
Lai, Francisco Tsz Tsun;
Chui, Celine Sze Ling;
Li, Xue;
Wong, Carlos King Ho;
Wan, Eric Yuk Fai;
Wong, Ian Chi Kei;
Chan, Esther Wai Yin

Publication type:

Article